Auxly Cannabis Group Inc
OTC:CBWTF

Watchlist Manager
Auxly Cannabis Group Inc Logo
Auxly Cannabis Group Inc
OTC:CBWTF
Watchlist
Price: 0.087 USD -8.42%
Market Cap: 109m USD

Relative Value

CBWTF doesn't have a meaningful market cap.

The Relative Value of one CBWTF stock under the Base Case scenario is 0.071 USD. Compared to the current market price of 0.087 USD, Auxly Cannabis Group Inc is Overvalued by 18%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CBWTF Relative Value
Base Case
0.071 USD
Overvaluation 18%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
38
vs Industry
70
Median 3Y
0.4
Median 5Y
0.7
Industry
2.5
Forward
0.9
vs History
0
vs Industry
Median 3Y
-0.3
Median 5Y
-1
Industry
21.6
vs History
9
vs Industry
47
Median 3Y
2.6
Median 5Y
-1.7
Industry
16.7
vs History
0
vs Industry
26
Median 3Y
-1
Median 5Y
-1.8
Industry
24
vs History
6
vs Industry
61
Median 3Y
0.4
Median 5Y
0.6
Industry
2.2
vs History
63
vs Industry
65
Median 3Y
1.1
Median 5Y
1.5
Industry
2.7
Forward
0.9
vs History
61
vs Industry
29
Median 3Y
4
Median 5Y
15.9
Industry
5.3
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-5.6
Industry
12.9
Forward
7.9
vs History
vs Industry
Median 3Y
-2.6
Median 5Y
-3.4
Industry
16.3
Forward
-21.7
vs History
28
vs Industry
45
Median 3Y
6.1
Median 5Y
-4.1
Industry
15.2
vs History
19
vs Industry
34
Median 3Y
4.6
Median 5Y
-5
Industry
17.7
vs History
28
vs Industry
66
Median 3Y
0.5
Median 5Y
0.5
Industry
1.9

Multiples Across Competitors

CBWTF Competitors Multiples
Auxly Cannabis Group Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Auxly Cannabis Group Inc
OTC:CBWTF
151.2m USD 1.2 6.9 -17.2 -7.8
US
Eli Lilly and Co
NYSE:LLY
738.3B USD 15.1 66.5 35.7 39
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
374.2B USD 4.2 17.2 12.5 16.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.9T DKK 6.3 18.4 12.7 14.6
CH
Roche Holding AG
SIX:ROG
202.8B CHF 3.4 24.5 9.2 10.8
CH
Novartis AG
SIX:NOVN
187.7B CHF 4.4 18.3 10.8 14.4
UK
AstraZeneca PLC
LSE:AZN
162.7B GBP 4 28.1 130.7 197.1
US
Merck & Co Inc
NYSE:MRK
205.5B USD 3.2 11.8 8.8 10.6
IE
Endo International PLC
LSE:0Y5F
184.8B USD 79.7 -63.2 294 737.3
US
Pfizer Inc
NYSE:PFE
140.7B USD 2.3 17.9 7.6 10.7
P/E Multiple
Earnings Growth PEG
CA
Auxly Cannabis Group Inc
OTC:CBWTF
Average P/E: 23.3
6.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
66.5
49%
1.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
17.2
27%
0.6
DK
Novo Nordisk A/S
CSE:NOVO B
18.4
18%
1
CH
Roche Holding AG
SIX:ROG
24.5
32%
0.8
CH
Novartis AG
SIX:NOVN
18.3
17%
1.1
UK
AstraZeneca PLC
LSE:AZN
28.1
36%
0.8
US
Merck & Co Inc
NYSE:MRK
11.8
17%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -63.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
17.9
30%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Auxly Cannabis Group Inc
OTC:CBWTF
Average EV/EBITDA: 436.8
Negative Multiple: -17.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35.7
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.5
7%
1.8
DK
Novo Nordisk A/S
CSE:NOVO B
12.7
13%
1
CH
Roche Holding AG
SIX:ROG
9.2
5%
1.8
CH
Novartis AG
SIX:NOVN
10.8
5%
2.2
UK
AstraZeneca PLC
LSE:AZN
130.7
10%
13.1
US
Merck & Co Inc
NYSE:MRK
8.8
8%
1.1
IE
E
Endo International PLC
LSE:0Y5F
294
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
2%
3.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Auxly Cannabis Group Inc
OTC:CBWTF
Average EV/EBIT: 1 875.3
Negative Multiple: -7.8
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.5
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
14.6
14%
1
CH
Roche Holding AG
SIX:ROG
10.8
6%
1.8
CH
Novartis AG
SIX:NOVN
14.4
10%
1.4
UK
AstraZeneca PLC
LSE:AZN
197.1
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.6
11%
1
IE
E
Endo International PLC
LSE:0Y5F
737.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.7
10%
1.1